今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

华为辟谣“最大牛肉进口商”传闻：莫塞尔仅为员工福利平台

北京，2024年6月18日 – 近日，网传华为为国内最大牛肉进口商的消息引发广泛关注。对此，华为于6月14日通过官方微博辟谣称，该消息纯属造谣，华为与牛肉进口业务没有任何关联。

华为官方表示，莫塞尔是华为旗下的一项品质生活平台，主要面向华为员工及家属提供包括严选商品、餐饮、旅行等服务，其中牛肉只是平台所提供的众多商品品类之一。华为并未从事任何牛肉进口业务，也从未发布过相关信息。

针对近期牛肉价格波动，华为呼吁公众不要轻信网络传言，理性看待市场价格变化。同时，华为也将继续为员工提供优质的福利服务，不断提升员工满意度。

事件回顾

6月13日，有网友在社交平台上发布消息称，华为是国内最大的牛肉进口商，并由此引发了对牛肉价格波动的猜测。该消息迅速在网络上传播，并引起广泛关注。

莫塞尔平台简介

莫塞尔平台是华为为回馈员工、提升员工生活品质而推出的专属福利平台。平台精选全球优质商品，提供包括食品、酒水、家居、母婴等品类，并定期推出优惠活动。华为员工及家属可以登录莫塞尔平台，享受专属福利和优惠价格。

澄清影响

华为此次辟谣澄清，有效地制止了虚假信息的传播，维护了公司的声誉。同时，也避免了网传信息对公众造成的误导和恐慌。

启示

近年来，随着网络信息的快速传播，虚假信息也更容易滋生蔓延。广大网民应谨慎对待网络信息，做到不造谣、不信谣、不传谣，共同维护健康清朗的网络空间。